Cytosorbents (CTSO) Notes Payables (2011 - 2014)

Cytosorbents (CTSO) has 4 years of Notes Payables data on file, last reported at $709338.0 in Q2 2014.

• For the quarter ending Q2 2014, Notes Payables fell 22.23% year-over-year to $709338.0; the trailing twelve-month figure through Jun 2014 stood at $709338.0 (down 22.23% YoY), and the FY2013 full-year result was $1.6 million, up 77.53% from the prior year.
• Notes Payables for Q2 2014 stood at $709338.0, down from $1.7 million in the prior quarter.
• Across five years, Notes Payables topped out at $1.7 million in Q1 2014 and bottomed at $238015.0 in Q3 2011.
• The 4-year median for Notes Payables is $973379.0 (2012), against an average of $1.0 million.
• The widest annual swing landed in 2012, when Notes Payables surged 308.96%; it then dropped 23.05% in 2013.
• A 4-year view of Notes Payables shows it stood at $294323.0 in 2011, then surged by 214.7% to $926225.0 in 2012, then soared by 77.53% to $1.6 million in 2013, then sank by 56.86% to $709338.0 in 2014.
• The last three Notes Payables figures came in at $709338.0 (Q2 2014), $1.7 million (Q1 2014), and $1.6 million (Q4 2013), per Business Quant data.

Peer Comparison